ICU Medical, Incorporated (ICUI) 2015年年度报告「NASDAQ」.pdf

1、2015 Annual Report to Shareholders and Form 10-KInfusion TherapyStandardize your clinical practice with our industry-leading needlefree IV connector technology,chosen by clinicians and infection control professionals worldwide more often than any other technology.OncologyHelp keep pharmacists,nurses

2、,and patients safe with the only needlefree closed system transfer devices and drug compounding systems for safely handling hazardous drugs.Easy-to-use,safe,effective,and affordable.Critical CareGet accurate,reliable,and real-time access to your patients cardiovascular and hemodynamic status with ou

3、r critical care products,including a full line of advanced sensor catheters with no natural rubber latex components.Clinicians Around the World Count on ICU Medical to provide them with clinically proven,cost-effective products and innovative patient safety solutions.April 4,2016 Dear Stockholder:Fi

4、scal year 2015 was a very good year for ICU Medical.The necessary actions and directed investments we made in 2014 enabled us to deliver revenue growth,gross margins,and adjusted EBITDA at record levels in the history of the company.As a result we created strong shareholder value during the year,and

5、 put ICU Medical in a better position to continue creating long-term value growth for shareholders,customers,and employees.As a reminder,the key actions taken in 2014 included:(i)aligning our cost base with our then-current revenue;(ii)continuing investment into our manufacturing platforms and quali

6、ty systems;(iii)improving the caliber of our direct selling force in the United States;(iv)aligning management incentives with shareholder objectives and ensuring the entire company participated by establishing a streamlined,measurable,and common set of company goals;and(v)continuing significant inv